Target Name: MUC19
NCBI ID: G283463
Other Name(s): Mucin 19, oligomeric | MUC-19 | mucin 19, oligomeric | Mucin-19 | MUC19_HUMAN

MUC19: A Potential Drug Target and Biomarker

MUC19, also known as Mucin 19 or oligomeric, is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and connective tissues. It is a member of the glycoprotein family and is characterized by its ability to form inclusion bodies with various signaling molecules, such as proteins and nucleic acids.

MUC19 has been identified as a potential drug target due to its involvement in a variety of cellular processes, including cell signaling, tissue repair, and inflammation. Its expression has also been linked to a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key challenges in studying MUC19 is its complex structure. MUC19 is a monomeric protein that consists of four transmembrane domains and a cytoplasmic tail. It has a large extracellular domain that is involved in various signaling processes, as well as a short cytoplasmic tail that is involved in protein-protein interactions.

MUC19 has been shown to play a role in a variety of cellular processes, including cell signaling, cell migration, and tissue repair. For example, MUC19 has been shown to be involved in the regulation of cell adhesion, a process that is critical for the development and maintenance of tissues and organs.

MUC19 has also been shown to play a role in the regulation of inflammation. Its expression has been linked to the development of a variety of inflammatory diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

One of the challenges in studying MUC19 is its complex structure and the difficulty of studying its function in a cell-free format. However, researchers have been able to use a variety of techniques to study its behavior, including biochemical assays, cell-based assays, and in vitro assays.

In addition to its potential drug-target properties, MUC19 has also been identified as a potential biomarker for a variety of diseases. Its expression has been linked to a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it an attractive target for researchers to study and potentially develop into a diagnostic or therapeutic tool.

Overall, MUC19 is a complex and fascinating protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its behavior and its role in various cellular processes.

Protein Name: Mucin 19, Oligomeric

Functions: May function in ocular mucus homeostasis

More Common Targets

MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8 | MYH9 | MYHAS | MYL1 | MYL10 | MYL11 | MYL12A | MYL12B | MYL12BP3 | MYL2 | MYL3 | MYL4 | MYL5 | MYL6 | MYL6B | MYL7